HCM - Hutchison China MediTech -  [ ]

Ticker Details
Hutchison China MediTech
Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.
IPO Date: March 17, 2016
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $2.63B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.43 | 1.93%
Avg Daily Range (30 D): $0.16 | 1.08%
Avg Daily Range (90 D): $0.15 | 1.00%
Institutional Daily Volume
Avg Daily Volume: .16M
Avg Daily Volume (30 D): .03M
Avg Daily Volume (90 D): .03M
Trade Size
Avg Trade Size (Sh.): 89
Avg Trade Size (Sh.) (30 D): 81
Avg Trade Size (Sh.) (90 D): 78
Institutional Trades
Total Institutional Trades: 925
Avg Institutional Trade: $1.84M
Avg Institutional Trade (30 D): $.73M
Avg Institutional Trade (90 D): $.68M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.1M
Avg Closing Trade (30 D): $.63M
Avg Closing Trade (90 D): $.63M
Avg Closing Volume: 88.57K
 
News
Feb 6, 2026 @ 8:30 AM
HUTCHMED to Announce 2025 Final Results
Source: Globe Newswire
Jan 14, 2026 @ 4:00 AM
HUTCHMED Highlights Publication of Phase III SACHI...
Source: Hutchmed (China) Limited
Jan 7, 2026 @ 12:00 AM
HUTCHMED Announces Positive Topline Results of Pha...
Source: Hutchmed (China) Limited
Jan 5, 2026 @ 12:00 AM
HUTCHMED Initiates Phase III Stage of the Ongoi...
Source: Hutchmed (China) Limited
Dec 29, 2025 @ 8:35 AM
HUTCHMED Announces NDA Acceptance in China with Pr...
Source: Na
Splits
Apr 20, 2009 1:50